SCYNEXIS Names Sanjay Subramanian CFO as Macleod Retires
The rare-disease biotech appointed a new finance chief effective September 9, with outgoing CFO Ivor Macleod staying on through October 9 for the handover.
The rare-disease biotech appointed a new finance chief effective September 9, with outgoing CFO Ivor Macleod staying on through October 9 for the handover.